1. Home
  2. Live Updates
  3. Simulations plus

Live Breaking News & Updates on Simulations plus

Stay informed with the latest breaking news from Simulations plus on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Simulations plus and stay connected to the pulse of your community

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

Total revenue of $18.3 million and diluted earnings per share of $0.20


Maintains full-year revenue guidance of $66 to $69 million and EPS guidance of $0.66 to $0.68

...

United-states , America , Shawn-oconnor , Asia-pacific , Linkedinx-youtube , Simulations-plus-inc , Software-performance-metrics , Services-performance-metrics , Company-adjusted , Nasdaq , Exchange-commission , Company-board-of-directors

Simulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year Guidance

Strong Revenue Growth and Dividend Declaration in Q2 Fiscal 2024

Shawn-oconnor , Simulations-plus-inc , Financial-health , Clinical-pharmacology , Simulations-plu , Simulations-plus , Rowth-trajectory , Evenue-growth , Arnings-per-share ,

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

Simulations Plus, Inc. ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second quarter fiscal 2024, ended February 29, 2024....

United-states , America , Asia-pacific , Shawn-oconnor , Linkedinx-youtube , Company-adjusted , Company-board-of-directors , Services-performance-metrics , Exchange-commission , Software-performance-metrics , Nasdaq , Simulations-plus-inc

Simulations Plus, Inc. (NASDAQ:SLP) Director Sells $798,800.00 in Stock

Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $39.94, for a total value of $798,800.00. Following the transaction, the director now owns 3,600,195 shares in the company, valued at […]

Craig-hallum , Walters-woltosz , Kayne-anderson-rudnick-investment-management , Barclays-plc , Securities-exchange-commission , Nasdaq , Lazard-asset-management , Simulations-plus-inc , Victory-capital-management-inc , Simulations-plus , Get-free-report , Director-walter

Simulations Plus, Inc. (NASDAQ:SLP) Director Sells $798,800.00 in Stock

Simulations Plus, Inc. (NASDAQ:SLP) Director Sells $798,800.00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Craig-hallum , Walters-woltosz , Securities-exchange-commission , Barclays-plc , Kayne-anderson-rudnick-investment-management , Simulations-plus-inc , Victory-capital-management-inc , Lazard-asset-management , Nasdaq , Simulations-plus , Get-free-report , Director-walter

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Simulations Plus, Inc. , a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that Shawn O’Connor, chief executive officer,...

Shawn-oconnor , Linkedinx-youtube , Nasdaq , Simulations-plus-inc , Simulations-plus , Shawno-connor , Keybanc-capital-markets-virtual-life-sciences , Medtech-investor-forum , Markets ,

Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible (NASDAQ:HCAT)

Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible (NASDAQ:HCAT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Health-catalyst , Evolent-health , Professional-services , Chart-abstraction , Simulations-plus ,

Simulations Plus Extends Collaboration with Major Toxicology Research Agency

Research project with NIEHS includes focus on qualification of in silico methods for prioritization, assessment of risk, and identification of safety margins for chemical use

...

Stephen-ferguson , Linkedinx-youtube , Cheminformatics-solutions , National-institute-of-environmental-health-sciences , Exchange-commission , Simulations-plus-inc , Translational-toxicology-division , Division-of-translational-toxicology , Nasdaq , Simulations-plus , National-institute , Environmental-health-sciences

Simulations Plus Extends Collaboration with Major Toxicology Research Agency

Simulations Plus Extends Collaboration with Major Toxicology Research Agency
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Stephen-ferguson , Linkedinx-youtube , Lisa-fortuna , Renee-bouche , Simulations-plus-inc , Nasdaq , National-institute-of-environmental-health-sciences , Translational-toxicology-division , Cheminformatics-solutions , Exchange-commission , Division-of-translational-toxicology , Simulations-plus

Simulations Plus Launches Corporate Development Initiative

Simulations Plus Launches Corporate Development Initiative
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Renee-bouche , Shawn-oconnor , Lisa-fortuna , Linkedinx-youtube , Exchange-commission , Nasdaq , Simulations-plus-inc , Emerging-technologies , Revenue-opportunities , Shareholder-returns , Will-frederick , Chief-financial-officer